通过以PEG为基础的胃阻系统提高黄素的生物可用性:开发和体外评估
Orsolya Csendes1,2, Gábor Vasvári1, Ádám Haimhoffer1
1Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Rex Ferenc St. 1, H-4002 Debrecen, Hungary.
Pharmaceutics
|September 27, 2025
概括
这项研究开发了一种新型的自我乳化胃制剂配方,以提高吸收不良药物的生物可用性,特别是针对黄素等BCS类IV化合物. 该配方使用具有成本效益的辅助剂证明了改善药物释放和胃保持.
科学领域:
- 制药技术 制药技术 制药技术
- 药物输送系统 药物输送系统
- 生物制药生物制药公司
背景情况:
- BCS IV类药物的生物可用性差 (溶解性和透性差) 是一个重大挑战.
- 在BCS IV类中的活性药物成分经常面临快速排泄和新陈代谢.
- 提高药物吸收和克服这些障碍对于有效的治疗方法至关重要.
研究的目的:
- 提高吸收不良药物的生物可用性,特别是BCS IV类化合物.
- 为了制定一个使用黄素作为模型药物的胃的自我乳化系统.
- 开发一种延长释放配方,增强胃留.
主要方法:
- 自乳化系统的配方,包括乳化剂,溶解阻滞剂和PEGs.
- 使用动态光散射和粘度测量进行水性分散的表征.
- 通过化泡,微CT,PXRD,DSC,细胞毒性测定和跨细胞运输研究来评估胃留.
主要成果:
- 开发一个均的,胃浮动的,自我乳化系统.
- 在Caco-2细胞中显示出有利的细胞毒性特征.
- 实现了增加生物可用性和延长药物释放时间.
结论:
- 成功创建了一种自我乳化胃的配方,以提高药物的生物可用性.
- 该配方表现出有效的胃保留和延长释放特性.
- 在配方开发中使用了最小数量的经济高效的辅助剂.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
200
Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
200
Bioavailability Enhancement: Drug Permeability Enhancement
186
Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
186
Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
183
Body:Bioavailability is a critical pharmacological concept that measures the extent and rate at which an active drug ingredient or therapeutic moiety enters the systemic circulation, remaining unchanged. It's a pivotal factor in determining a drug's efficacy and safety.The Biopharmaceutics Classification System (BCS) plays an essential role in drug development by categorizing drugs into four classes based on their solubility and permeability. This classification aids in understanding drug...
183
Bioavailability Enhancement: Drug Solubility Enhancement
221
Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
221
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
505
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
505
Methods for Studying Drug Absorption: In vitro
574
In vitro experiments are crucial for understanding the transport and absorption of drugs through biological materials. These studies employ varied methods such as the diffusion cell method, the everted sac technique, and the everted ring technique.
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
The diffusion cell method uses a two-compartment cell, including a donor compartment with the drug solution, which simulates the environment where the drug is applied, and a receptor compartment with a buffer solution, which simulates the environment...
574


